Back to Trades
Sell4
Slide Insurance Holdings, Inc.
SLDE
Total Value
$7.2M
Net $7.1M sold
Sales
$7.1M
3 transactions
Company Information
- Company Name
- Slide Insurance Holdings, Inc.
- Ticker Symbol
- SLDE
- CIK
- 0001886428
Insider Information
- Name
- Lucas Bruce
- Role
- Insider
- Location
- TAMPA, FL
Filing Details
- Filing Date
- Apr 1, 2026
- Transaction Date
- Mar 30, 2026
- Accession Number
- 0001193125-26-138646
- Form Type
- 4
- Net Trading Amount
- -$7.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | 135,376 | $18.09 | Sale | $2.4M |
| Mar 31, 2026 | Common Stock | 247,008 | $18.10 | Sale | $4.5M |
| Apr 1, 2026 | Common Stock | 8,771 | $18.01 | Sale | $158.0K |
| Mar 31, 2026 | Common Stock | 22,919 | — | Exercise | — |
| Mar 31, 2026 | Common Stock | 9,019 | $18.00 | Tax Withholding | $162.3K |
| Mar 31, 2026 | Common Stock | 22,919 | — | Exercise | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Derivative | 22,919 | — | Exercise | — |
| Mar 31, 2026 | Derivative | 22,919 | — | Exercise | — |
Footnotes
- (F1)Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- (F2)Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.21 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F3)The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- (F4)Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.21 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F5)Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.05 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- (F6)The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,919 restricted stock units on March 31, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.
- (F7)Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- (F8)The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 38,686 shares of common stock between March 30 through April 1, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.00 to $18.21 per share.
- (F9)Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- (F10)Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- (F11)Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- (F12)Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock
- (F13)These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.